Novartis Ag (NVS) Dividend Coverage Ratio (2009 - 2026)
Novartis Ag's (NVS) quarterly Dividend Coverage Ratio came in at 1.14 in Q2 2026, up 30.09% year-over-year from 0.87 in Q2 2025, and down 55.8% quarter-over-quarter from 0.73 in Q1 2026.
Analysis
Novartis Ag (NVS) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Dividend Coverage Ratio across 18 years of filings, most recently posting 1.14 for Q2 2026.
- In Q2 2026, Dividend Coverage Ratio rose 30.09% year-over-year to 1.14; the TTM figure through Jun 2026 stood at 1.33 (up 15.78% YoY), while the FY2025 annual figure was 1.79, down 14.2% from the prior year.
- Dividend Coverage Ratio came in at 1.14 for Q2 2026 at Novartis Ag, down from 0.73 in the prior quarter.
- In the past five years, Dividend Coverage Ratio ranged from a high of 0.42 in Q1 2022 to a low of 1.63 in Q2 2025.
- Average Dividend Coverage Ratio over 5 years is 1.02, with a median of 1.06 recorded in 2026.
- Year-over-year, Dividend Coverage Ratio slumped 63.95% in 2024 and jumped 30.09% in 2026.
- Over 5 years, Dividend Coverage Ratio stood at 0.42 in 2022, then fell by 0.64% to 0.42 in 2023, then slumped by 263.55% to 1.52 in 2024, then rose by 13.82% to 1.31 in 2025, then grew by 13.23% to 1.14 in 2026.
- Per Business Quant data, the three most recent Dividend Coverage Ratio figures were 1.14 in Q2 2026, 0.73 in Q1 2026, and 1.31 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.10 Bn | 627.34 Bn | 17.26 Bn | 1.71 |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn | 1.18 |
| 3 | Merck | 364.97 Bn | 357.83 Bn | 12.21 Bn | -0.62 |
| 4 | Novartis Ag | 267.08 Bn | 259.39 Bn | 11.24 Bn | 1.14 |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn | -0.10 |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 0.07 |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.14 |
| Mar 31, 2026 | -0.73 |
| Dec 31, 2025 | -1.31 |
| Jun 30, 2025 | -1.63 |
| Mar 31, 2025 | -0.98 |
| Dec 31, 2024 | -1.52 |
| Jun 30, 2024 | -1.34 |
| Mar 31, 2024 | -0.69 |
| Mar 31, 2023 | -0.42 |
| Mar 31, 2022 | -0.42 |
| Mar 31, 2021 | -0.39 |
| Dec 31, 2020 | 0.84 |
| Mar 31, 2020 | -0.44 |
| Dec 31, 2019 | -1.90 |
| Mar 31, 2019 | -0.44 |
| Mar 31, 2018 | -0.39 |
| Mar 31, 2017 | -0.34 |
| Dec 31, 2016 | -0.79 |
| Mar 31, 2016 | -0.42 |
| Dec 31, 2015 | -0.83 |